You are here

Zostavax

Merck puts 1,000-plus Zostavax lawsuits to bed after plaintiffs file for dismissal

Fierce Pharma

Tue, 07/9/24 - 11:23 am

The never-ending Zostavax story – in court. Merck gets a win, but thousands more lawsuits pending

Endpoints

Wed, 04/13/22 - 05:15 pm

Gardasil grows, Zostavax struggles as Merck posts $6.5B in 2017 vaccine sales

Fierce Pharma

Tue, 02/6/18 - 08:38 pm

Vaccine approval buoys GSK new drug push

Biopharma Dive

Mon, 10/23/17 - 09:48 pm

GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on

Endpoints

Thu, 09/14/17 - 09:54 am

Merck’s Zostavax draws new litigation from patients alleging they contracted shingles

Fierce Pharma

Fri, 07/21/17 - 11:18 am

Zostavax patients sue Merck, claiming shingles shot caused injuries and death

Fierce Pharma

Tue, 03/14/17 - 04:38 pm

Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016

Yahoo

Wed, 10/26/16 - 09:05 am

infectious diseases

GSK files potential $1 bln shingles vaccine for U.S. approval

Yahoo/Reuters

Mon, 10/24/16 - 09:58 am

Analysts: GSK shingles vaccine could steal market share from Merck's Zostavax

Fierce Vaccines

Fri, 04/3/15 - 08:37 am

GSK shingles vax shaping up to compete with Merck's

Medical Marketing and Media

Tue, 12/23/14 - 10:39 am

Merck’s Shingles Vaccine Not Reaching Enough U.S. Adults

Bloomberg

Wed, 09/11/13 - 03:33 pm

Merck poised for expansion of Zostavax shingles vax as demand grows

Fierce Pharma

Fri, 09/6/13 - 09:17 am

Merck's Promising Vaccine Empire

Seeking Alpha

Fri, 04/19/13 - 08:47 am

Merck's New Vaccine, Partnerships Will Drive Stock Higher

Seeking Alpha

Tue, 04/17/12 - 10:22 am

With Zostavax supplies restored, Merck aims for revival

Fierce Pharma

Mon, 04/16/12 - 01:46 pm

Ample Supplies of Shingles Vaccine Return

WSJ

Sat, 04/14/12 - 12:38 pm

Merck: High Upside Expected From Vaccine

Seeking Alpha

Wed, 04/4/12 - 08:32 am

ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59

Yahoo/BusinessWire

Sat, 03/26/11 - 10:10 am

FDA OKs shingle vaccine for those aged 50 to 59

Reuters

Fri, 03/25/11 - 09:50 am

Pages